IL-2/anti-IL-2 antibody immune complexes, as well as complexes involving other cytokines, have been considered for treatment in immuno-oncology, auto-immune disorders, viral and bacterial infections, and multiple sclerosis [13,19–24]. Here, IL2 is linked to multiple sclerosis.